G Carcelain

Summary

Country: France

Publications

  1. ncbi T cell changes after combined nucleoside analogue therapy in HIV primary infection
    G Carcelain
    Laboratoire d Immunologie Cellulaire, CNRS UMR 7527, Hopital Pitie Salpetriere, Paris, France
    AIDS 13:1077-81. 1999
  2. ncbi Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
    B Autran
    Laboratoire d Immunologie Cellulaire, URA CNRS 625, Hopital Pitie Salpetriere, 47 83 boulevard de l Hopital, Paris, France
    Science 277:112-6. 1997
  3. ncbi Fetal death as a result of placental immune reconstitution inflammatory syndrome
    F Caby
    Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, Assistance Publique des Hopitaux de Paris AP HP, Paris, France
    J Infect 61:185-8. 2010
  4. ncbi Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
    M Jouan
    Department of Infectious Diseases, , Paris, France
    AIDS 15:23-31. 2001
  5. ncbi Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy
    G Carcelain
    Laboratoire d'Immunologie Cellulaire et Tissulaire, , , , 75013, Paris, France
    Curr Opin Immunol 13:483-8. 2001
  6. ncbi High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients
    E Oksenhendler
    Department of Immunology and Hematology, Laboratory of Virology, Hopital Saint Louis, Paris, France
    Blood 96:2069-73. 2000
  7. ncbi Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients
    N Simonney
    EA3510, UFR Denis Diderot, Université Paris VII et Service de Microbiologie, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, CIB HOG, Paris, France
    Tuberculosis (Edinb) 88:453-61. 2008
  8. ncbi Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure
    C Delaugerre
    Department of Virology, , Paris, France
    AIDS 15:2189-91. 2001

Collaborators

Detail Information

Publications8

  1. ncbi T cell changes after combined nucleoside analogue therapy in HIV primary infection
    G Carcelain
    Laboratoire d Immunologie Cellulaire, CNRS UMR 7527, Hopital Pitie Salpetriere, Paris, France
    AIDS 13:1077-81. 1999
    ..To characterize the immune changes after treatment of acute HIV-1 infection with triple nucleoside analogue therapy...
  2. ncbi Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
    B Autran
    Laboratoire d Immunologie Cellulaire, URA CNRS 625, Hopital Pitie Salpetriere, 47 83 boulevard de l Hopital, Paris, France
    Science 277:112-6. 1997
    ..Thus, decreasing the HIV load can reverse HIV-driven activation and CD4(+) T cell defects in advanced HIV-infected patients...
  3. ncbi Fetal death as a result of placental immune reconstitution inflammatory syndrome
    F Caby
    Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, Assistance Publique des Hopitaux de Paris AP HP, Paris, France
    J Infect 61:185-8. 2010
    ..This outcome remains undescribed and could represent an issue in resource-limited settings where HIV-pregnant patients are often severely immunodeficient and infected with opportunistic pathogens...
  4. ncbi Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
    M Jouan
    Department of Infectious Diseases, , Paris, France
    AIDS 15:23-31. 2001
    ..CONCLUSIONS: CMV retinitis maintenance therapy may be safely discontinued in patients with CD4 cell counts above 75 x 10(6) cells/l who have been taking HAART for at least 18 months...
  5. ncbi Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy
    G Carcelain
    Laboratoire d'Immunologie Cellulaire et Tissulaire, , , , 75013, Paris, France
    Curr Opin Immunol 13:483-8. 2001
    ..The optimism that has been raised by the restoration of hosts' defenses against opportunistic pathogens is, however, balanced by the poor immunity restored against HIV; thus, innovative immune interventions are required...
  6. ncbi High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients
    E Oksenhendler
    Department of Immunology and Hematology, Laboratory of Virology, Hopital Saint Louis, Paris, France
    Blood 96:2069-73. 2000
    ..Strong correlations between plasma IL-6 and plasma IL-10 with the HHV8 viral load suggest that both cytokines may be involved in the pathogenesis of this virus-associated lymphoproliferative disorder...
  7. ncbi Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients
    N Simonney
    EA3510, UFR Denis Diderot, Université Paris VII et Service de Microbiologie, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, CIB HOG, Paris, France
    Tuberculosis (Edinb) 88:453-61. 2008
    ....
  8. ncbi Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure
    C Delaugerre
    Department of Virology, , Paris, France
    AIDS 15:2189-91. 2001
    ..The outgrowth of residual wild-type virus seems not to be a true genetic reversion because drug mutations are detected rapidly at salvage therapy re-initiation...